![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » CEPTOR CORPORATION TO RECEIVE $1.5 MILLION FROM JCR PHARMACEUTICALS UPON IND FILING
CEPTOR CORPORATION TO RECEIVE $1.5 MILLION FROM JCR PHARMACEUTICALS UPON IND FILING
CepTor Corporation (OTCBB:CEPO), a development-stage biopharmaceutical company focusing on cell targeted therapeutic products for neuromuscular and neurodegenerative diseases, today announced that it will receive a $1.5 million milestone payment from JCR Pharmaceuticals of Japan upon filing an Investigational New Drug (IND) application for Myodur (C-101) in muscular dystrophy. The payment will include $1 million in equity at the then current market price and $500,000 in cash.
Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20051020005467&newsLang=en)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct